
|Articles|May 8, 2019
hyperCORE International Launches
Advertisement
Announcing the launch of hyperCORE International LLP, a super network of eight Clinical Research Site Organizations. The primary goal of the super network is to modernize the highly fragmented and inefficient research site model. They will have more than 80 sites across two continents spanning from Peru to Canada at their launch.
For more informaton, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
3
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
4
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
5




